Skip to content
TrialScanner

NCT05093634

EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway

Phase 3CompletedRYTMLead

Registry record

Lead sponsor
Rhythm Pharmaceuticals, Inc.
Conditions
Obesity; Genetic Obesity
Primary completion
Dec 19, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05093634 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

2 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05093634: EMANATE: A Study of Setmelano... | TrialScanner